Navigation Links
No Benefit in Testing for Genes Linked to Leg Clots
Date:6/16/2009

Taking precautions best way to avoid deep vein thrombosis, report says

TUESDAY, June 16 (HealthDay News) -- There's no proof that genetic testing can help prevent the potentially dangerous blood clots called deep vein thrombosis, a new U.S. government report shows.

The presence of two gene mutations called Factor V Leiden and prothrombin G20210A can signal continued risk of blood clots, according to background information in the study.

But Agency for Healthcare Research and Quality (AHRQ) researchers reviewed available scientific literature and said there's not enough evidence to conclude that genetic testing for the two gene mutations in adults with a history of blood clots helps prevent deep vein thrombosis or improves other patient outcomes.

The researchers also said they found no benefit to genetic testing of family members of patients who have at least one of the two gene mutations as well as a history of deep vein thrombosis.

The study appears in the June 17 issue of the Journal of the American Medical Association.

Each year, an estimated 600,000 Americans develop deep vein thrombosis. These blood clots occur most commonly in the legs of people who are immobile for a long period of time, such as when traveling long distances or recovering from surgery. A deep vein thrombosis can break loose and cause a serious lung problem called pulmonary embolism, or a heart attack or stroke.

"While genetic testing shows great promise to improve treatment and prevent disease, this report clearly shows that we need more research and evidence to achieve its full potential. But people can help reduce their likelihood of developing a blood clot by talking with their doctor about precautions," Dr. Carolyn M. Clancy, AHRQ director, said in a news release from the agency.

More information

The Society for Vascular Surgery has more about deep vein thrombosis.



-- Robert Preidt



SOURCE: U.S. Agency for Healthcare Research and Quality, news release, June 16, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
2. Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia
3. Discovery of sugar sensor in intestine could benefit diabetes
4. Study shines more light on benefit of vitamin D in fighting cancer
5. Vitamin Es lack of heart benefit linked to dosage
6. Practice-based intervention has sustained benefits for children and families
7. Manic phase of bipolar disorder benefits from breast cancer medication
8. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
9. Scientists highlight benefits of genetic research in sport, but warn of ethical concerns
10. The Butterfly Ball to Benefit Lung Association
11. Smaller breast reduction surgeries provide health benefits and should be reimbursed
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
No Benefit in Testing for Genes Linked to Leg Clots
(Date:6/25/2016)... ... , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department ... in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at ... Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Research and Markets has announced the ... 2016 - Forecast to 2022" report to their offering. ... up to date financial data derived from varied research sources ... with potential impact on the market during the next five ... comprises of sub markets, regional and country level analysis. The ...
(Date:6/23/2016)... 2016 Bracket , a leading clinical trial ... clinical outcomes platform, Bracket eCOA (SM) 6.0, at the ... – 30, 2016 in Philadelphia , Pennsylvania.  ... Assessment product of its kind to fully integrate with RTSM, ... eCOA 6.0 is a flexible platform for electronic clinical outcomes ...
Breaking Medicine Technology: